- Home
- OCFT vs LYEL Comparison
OCFT vs LYEL Comparison
Compare OCFT & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- LYEL
- Stock Information
- Founded
- OCFT 2015
- LYEL 2018
- Country
- OCFT China
- LYEL United States
- Employees
- OCFT N/A
- LYEL N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- OCFT Technology
- LYEL Health Care
- Exchange
- OCFT Nasdaq
- LYEL Nasdaq
- Market Cap
- OCFT 294.4M
- LYEL 253.2M
- IPO Year
- OCFT 2019
- LYEL 2021
- Fundamental
- Price
- OCFT $7.63
- LYEL $17.38
- Analyst Decision
- OCFT Hold
- LYEL Hold
- Analyst Count
- OCFT 1
- LYEL 3
- Target Price
- OCFT $7.98
- LYEL $16.67
- AVG Volume (30 Days)
- OCFT 16.9K
- LYEL 39.0K
- Earning Date
- OCFT 11-13-2025
- LYEL 11-06-2025
- Dividend Yield
- OCFT N/A
- LYEL N/A
- EPS Growth
- OCFT N/A
- LYEL N/A
- EPS
- OCFT N/A
- LYEL N/A
- Revenue
- OCFT $228,020,185.00
- LYEL $60,000.00
- Revenue This Year
- OCFT N/A
- LYEL N/A
- Revenue Next Year
- OCFT $6.37
- LYEL N/A
- P/E Ratio
- OCFT N/A
- LYEL N/A
- Revenue Growth
- OCFT N/A
- LYEL 11.11
- 52 Week Low
- OCFT $2.08
- LYEL $7.65
- 52 Week High
- OCFT $7.75
- LYEL $30.00
- Technical
- Relative Strength Index (RSI)
- OCFT 66.09
- LYEL 60.74
- Support Level
- OCFT $7.44
- LYEL $16.48
- Resistance Level
- OCFT $7.68
- LYEL $18.08
- Average True Range (ATR)
- OCFT 0.10
- LYEL 1.19
- MACD
- OCFT 0.00
- LYEL -0.13
- Stochastic Oscillator
- OCFT 79.17
- LYEL 46.07
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a technology-as-a-service provider for the financial services industry. It integrates extensive expertise in the industry with market technology to provide technology applications and technology-enabled business services to financial institutions. The integrated solutions and platforms it provides include digital banking solutions, digital insurance solutions, and the Gamma Platform, a technology infrastructure platform for financial institutions. Geographically, the company generates substantially all of its revenue from its business in the People's Republic of China (PRC).
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.